Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00955448
Other study ID # Anterior SIS 300609
Secondary ID Ethics: E-22217
Status Completed
Phase Phase 3
First received August 5, 2009
Last updated August 29, 2016
Start date December 2009
Est. completion date April 2012

Study information

Verified date August 2016
Source University of Calgary
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Prolapse occurs when pelvic organs drop down and cause a bulging of the tissues. An "anterior wall prolapse" occurs when the front of the vagina loses its support, and the bladder drops down and rotates into the vaginal opening. The bladder can cause a bulge out of the vagina.

One of the treatment options available is to repair the anterior wall surgically. The goals of surgery are to return the anatomy to its usual position, ensuring that all the pelvic floor organs (bladder, vagina and rectum) can function properly. The ideal surgical repair would also be long lasting.

Two surgical options are routinely performed in Calgary for repair of an anterior compartment prolapse. One option involves fixing the organs back in place using sutures. The other option uses sutures plus a mesh made of small intestine submucosa (SIS) that is already licensed for use in Canada. The SIS mesh is slowly absorbed after it is placed in the pelvic area. The investigators do not know which of these two options is the best surgical procedure. Both may have different advantages that would result in better results. This study is designed to try and find out if one of these procedures is better, and if a larger study may be needed.


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Women who require surgical correction for anterior compartment prolapse. (Concomitant surgery is permitted.)

- Point Ba of 0 or greater: that is a positive Ba, indicating that the prolapse is beyond the introitus, not within the vagina.

- Patient must consent to participate in the study.

Exclusion Criteria:

- Having an obliterative procedure (Lefort procedure or colpocleisis).

- Allergy to graft material.

- Immunocompromised.

- Previous anterior compartment repair.

- Are unable to understand English.

- Will be unavailable for follow-up.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Device:
SIS mesh (Cook Medical)
Anterior prolapse repair will be reinforced using surgical mesh made from porcine small intestine mucosa (Cook Medical)
Procedure:
Anterior prolapse repair
Anterior prolapse repair will be conducted without using mesh reinforcement

Locations

Country Name City State
Canada Foothills Medical Centre Calgary Alberta

Sponsors (3)

Lead Sponsor Collaborator
University of Calgary Alberta Health Services, Cook

Country where clinical trial is conducted

Canada, 

References & Publications (1)

Robert M, Girard I, Brennand E, Tang S, Birch C, Murphy M, Ross S. Absorbable mesh augmentation compared with no mesh for anterior prolapse: a randomized controlled trial. Obstet Gynecol. 2014 Feb;123(2 Pt 1):288-94. doi: 10.1097/AOG.0000000000000105. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Objective assessment of prolapse. "Cure" is defined as point Ba (on POP-Q) of -1 or above (i.e., more negative) 12 months postoperatively No
Secondary Change in point Ba (on POP-Q) from baseline 12 months postoperatively No
Secondary Pelvic Organ Prolapse Quantification(POP-Q) stage 12 months postoperatively No
Secondary Change in POP-Q stage from baseline 12 months postoperatively No
Secondary Postoperative complications 12 months postoperatively Yes
Secondary Pelvic Floor Distress Inventory short form-20 (PFDI-20) 12 months postoperatively No
Secondary Pelvic Floor Impact Questionnaire short form-7 (PFIQ-7) 12 months postoperatively No
Secondary Sexual function (Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire (PISQ-12) 12 months postoperatively Yes
Secondary Surgical complications Up to 6 weeks postoperatively Yes
Secondary Satisfaction with surgical outcome 12 months postoperatively No